| Ytd | -4.18% | |
| 1y | -11.92% |
| Open | 2.21 | Prev Close | 2.20 | Low | 2.20 | High | 2.29 | Mkt Cap | 69.82M |
| Vol | 88.03K | Avg Vol | 39.92K | EPS | -1.54 | P/E | N/A | Forward P/E | 34.62 |
| Beta | 0.79 | Short Ratio | 15.03 | Inst. Own | 16.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 07-15 | Earning | 08-15 | 50-d Avg | 2.23 | 200-d Avg | 2.36 | 1yr Est | 13.00 |
XBIT News
XBiotech Inc. (NASDAQ: XBIT - Get Free Report)'s stock price passed below its fifty day moving avera
XBiotech Inc. (NASDAQ:XBIT) today announced that its Investigational New Drug (IND) application for
IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path f
XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.18) per share. This is a 50 percent increase
IN8bio (NASDAQ: INAB - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are both small
Psyence Biomedical (NASDAQ: PBM - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
XBiotech Inc. (NASDAQ: XBIT - Get Free Report) passed above its 50 day moving average during trading
XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.20) per share. This is a 25 percent decrease
XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.06) per share. This is a 86.05 percent incre
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder righ
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder righ
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 27, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 26, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 23, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 22, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 19, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national shareholder
LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder
On Monday, 79 companies reached new 52-week lows.
Thursday saw 177 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Tuesday, 507 stocks hit new 52-week lows.
On Monday, 429 stocks made new 52-week lows.
On Wednesday, 238 companies achieved new lows for the year.
On Monday, 195 stocks hit new 52-week lows.
On Friday, 109 stocks hit new 52-week lows.
On Monday, 92 companies set new 52-week lows.
On Thursday, 550 companies achieved new lows for the year.
During the Thursday's session, 100 stocks hit new 52-week lows.
On Tuesday, 540 companies set new 52-week lows.
On Monday, 198 companies reached new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
On Monday, 721 companies achieved new lows for the year.
On Thursday, 236 companies hit new 52-week lows.
On Monday, 466 companies hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
During Thursday, 166 stocks hit new 52-week lows.
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M
80 Biggest Movers From Yesterday
Mid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher
48 Stocks Moving In Monday's Mid-Day Session
Mid-Day Market Update: Synthorx Jumps Following Acquisition News; Biocept Shares Plunge
Mid-Morning Market Update: Markets Mixed; Merck To Acquire ArQule For $20/Share